摩根大通
共 878 份研报 · 海外机构
超微电脑(SMCI.US):新任CFO任命消除关键悬念
Super Micro (SMCI): New CFO Appointment Removes a Key Overhang
摩根大通·2026-10-15·8 页·美股
资本市场与财富管理、中国国有银行(下调交行H股评级)、友邦保险(印度业务?)
Capital Markets and Wealth, China SOE Banks (d/g BoComm-H), AIA (India?)
摩根大通·2026-10-15·8 页·金融
中国:信贷反弹掩盖贷款持续疲软
China: Credit rebound masks persistent loan weakness
摩根大通·2026-10-15·9 页·中国经济
维萨与万事达卡:2026年三季度业绩前瞻,对健康的运营与定价环境保持建设性看法
Visa / Mastercard C3Q26 Earnings Preview - Lean Constructive on Healthy Operating & Pricing Environment
摩根大通·2026-10-15·27 页·金融
腾讯控股(0700.HK):2026年三季度前瞻:AI战略成为焦点,回报周期较长
Tencent (0700.HK): 3Q26 preview: AI strategy comes into focus; the payoff takes longer
摩根大通·2026-10-15·14 页·港股
美国银行三季报的交叉启示:业绩强劲但盈利可持续性表态缺乏说服力——更看好估值更低的欧洲银行(2028年预期市盈率8.7倍)
Read-across from US banks 3Q: strong results with unconvincing messaging on earnings sustainability – prefer cheaper European Banks at 8.7x P/E 2028E
摩根大通·2026-10-15·15 页·金融
美国银行(BAC.US):三季度业绩疲软,费用高企、中间业务收入下滑、净利息收入符合预期,声誉与信心成核心担忧
Bank of America — Weak 3Q: Expenses High, Fees Down, NII On Track; Reputation, Confidence Are Key Concerns
摩根大通·2026-10-15·13 页·美股
京东集团(JD.US & 9618.HK):2026年三季度前瞻:盈利复苏有赖于费用管控
JD.com (JD US & 9618 HK): 3Q26 preview: Earnings recovery hinges on spending discipline
摩根大通·2026-10-15·15 页·美股
好时(HSY.US):2026年三季度前瞻:OSG相关风险引发股价震荡,不过四季度业务若再度提速或将带来惊喜
Hershey Co. (HSY.US): 3Q26 Preview - OSG Risk Has Spooked the Shares, Though a Reacceleration in 4Q Could Be a Treat
摩根大通·2026-10-15·19 页·美股
格芯(GFS.US):依托日本支持的业务扩张带来轻资本盈利来源并巩固美国市场布局;大部分业绩增量属于长期逻辑
GlobalFoundries Japan-Backed Expansion Adds Capital-Light Earnings Stream and Solidifies U.S. Footprint; Bulk of Uplift a Long-Term Story
摩根大通·2026-10-15·9 页·美股
道富集团(STT.US):三季度表现稳健;上调2026财年指引,净利息收入指引偏保守?四季度回购规模或将大幅提升
Decent 3Q; FY26 Guidance Raised, NII Guide Conservative? Buybacks Likely Sharp Step Up In 4Q
摩根大通·2026-10-15·13 页·美股
艾伯森(ACI.US):评级下调至"中性";挑战持续,叠加新一轮审查,盈利修复或延后
Albertsons (ACI): Downgrading to Neutral — Lingering Challenges and Another Review Could Delay Earnings Recovery
摩根大通·2026-10-15·15 页·美股
Rhythm Pharmaceuticals:首选投资标的,纳入分析师重点关注名单,受当前水平估值脱节驱动
Rhythm Pharmaceuticals: TOP IDEA - Adding to Analyst Focus List; Driven by Valuation Disconnect at Current Levels
摩根大通·2026-10-15·11 页·美股
MGE能源(MGEE.US):无名数据中心所在地,稳健的基础增长与有限的大负荷可见度及高溢价估值相平衡,首次覆盖评级为中性
MGE Energy (MGEE): Where the Data Centers Have No Name: Durable Base Growth Balanced By Limited Large-Load Visibility and Premium Valuation; Initiate at Neutral
摩根大通·2026-10-15·25 页·美股
Hemab Therapeutics(COAG.US):首次覆盖给予“增持”,具备独特优势的出血性疾病研发管线
Initiating Overweight – A Pipeline for Bleeding Disorders with the X-Factor
摩根大通·2026-10-15·28 页·美股
Glencore(GLC.AX):多元化综合资源巨头,具备一级铜矿资产敞口与被低估的增长管线;首次覆盖并给予"增持"评级
Diversified major – Tier 1 copper exposure with undervalued growth pipeline; initiate coverage of GLC AU with an Overweight rating
摩根大通·2026-10-15·44 页·其它
ACS(ACS.MC):市场对数据中心业务的担忧掩盖了亮眼的增长与估值逻辑;首次覆盖并给予"增持"评级
ACS: Datacentre fears obscure a compelling growth and valuation story: Initiate with OW
摩根大通·2026-10-15·45 页·其它
中国:信贷反弹掩盖了贷款需求持续疲软的现实
China: Credit rebound masks persistent loan weakness
摩根大通·2026-10-15·9 页·中国经济
台湾率先推向市场
Taiwan Surface Mount Tech (6278 TT): AI mix to rise from current <5% to >30% by 2027
摩根大通·2026-10-15·5 页·其它
台湾表面贴装技术:AI产品组合占比将从当前不足5%提升至2027年超过30%
Taiwan Surface Mount Tech: AI mix to rise from current <5% to >30% by 2027
摩根大通·2026-10-15·13 页·其它
显示 461 - 480 条,共 973 条